share_log

EXCLUSIVE: Vivani Medical Tells Benzinga 'Study Represents the First Clinical Application of NanoPortal, the Company's Proprietary Drug Implant Platform Technology'

Benzinga ·  Dec 19, 2024 21:00
EXCLUSIVE: Vivani Medical Tells Benzinga 'Study Represents the First Clinical Application of NanoPortal, the Company's Proprietary Drug Implant Platform Technology'
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment